Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-07-28

Oric Pharmaceuticals (ORIC)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$5,567,164
Jacob Chacko total, FY2025
CEO pay percentile vs peers
CEO-to-median pay ratio
98.6%
Say-on-pay support, latest vote
Companies that benchmark against ORIC
4 companies name ORIC as a compensation peer

Each company listed discloses ORIC in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ORIC in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Jacob Chacko$657,500$0$826,000$3,634,560$434,000$0$15,104$5,567,164
President, Chief Executive Officer and Director
Pratik Multani513,3330280,8401,226,664246,500015,1042,282,441
Chief Medical Officer
Dominic Piscitelli482,9170280,8401,226,664231,900015,1042,237,425
Chief Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Jacob Chacko$5,567,164
Pratik Multani2,282,441
Dominic Piscitelli2,237,425

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Richard A. HeymanDirector2026-07-06D300$12$3,600CommonForm 4 ↗
Richard A. HeymanDirector2026-07-24A3,50025,600CommonForm 4 ↗
Richard A. HeymanDirector2026-07-24D6,1001273,322CommonForm 4 ↗
Richard A. HeymanDirector2026-07-24D3,50000Derivative, Class A CommonForm 4 ↗
Richard A. HeymanDirector2026-07-24D7,0001284,140CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Jacob ChackoPSU$826,000
Jacob ChackoOPTION3,634,560
Dominic PiscitelliOPTION1,226,664
Pratik MultaniOPTION1,226,664
Dominic PiscitelliPSU280,840
Pratik MultaniPSU280,840
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Jacob Chacko$0$826,000$3,634,56018.5%
Dominic Piscitelli0280,8401,226,66418.6%
Pratik Multani0280,8401,226,66418.6%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Pratik MultaniRSU22,667$185,416
Pratik MultaniOption93,7509.14
Pratik MultaniRSU10,00081,800
Pratik MultaniOption28,9854.36
Jacob ChackoOption600,0008.26
Dominic PiscitelliOption93,7509.14
Pratik MultaniOption202,5008.26
Jacob ChackoOption84,5844.36
Jacob ChackoOption850,5001.6
Jacob ChackoOption437,5004.36
Pratik MultaniOption231,2501.6
Jacob ChackoRSU66,667545,336
Pratik MultaniOption147,5004.36
Jacob ChackoRSU28,334231,772
Dominic PiscitelliOption28,9854.36
Jacob ChackoOption265,6259.14
Jacob ChackoOption116,6676
Dominic PiscitelliRSU22,667185,416
Dominic PiscitelliRSU10,00081,800
Dominic PiscitelliOption42,2926
Pratik MultaniOption42,2926
Dominic PiscitelliOption202,5008.26
Dominic PiscitelliOption282,7504.36
05

Incentive-plan design — the Compensation Discussion & Analysis

Base salary is set at a level that is commensurate with the named executive officer's duties and authorities, contributions, prior experience and sustained performance. We design our employee benefits programs to be affordable and competitive in relation to the market, as well as compliant with applicable laws and practices.

CEO STI target (% of salary)55%
CEO LTI target (% of salary)
Independent consultantAon
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-1888,453,8091,250,0742,37398.6%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-06-1898.6%a

a. Approved under the standard stated in the filing — “As a result, abstentions will be counted for purposes of determining the presence or absence of a quorum and will also count as votes against a proposal in cases where approval of the proposal requires the affirmative vote of a majority of the voting power of the shares present in person (virtually) or represented by proxy at the Annual Meeting and entitled to vote on the subject matter ( e.g.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)
CEO total compensation
Median employee compensation
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Richard Heyman, Ph.DIndependent · Board Chair · Compensation (Chair) · Nominating/Governance (Chair)$100,000$0$206,021$0$0$306,021
Mardi C. DierIndependent · Audit (Chair) · Nominating/Governance60,0000206,02100266,021
Angie You, Ph.DIndependent · Audit · Nominating/Governance52,5000206,02100258,521
Steven L. HoerterIndependent · Audit · Compensation52,5000206,02100258,521
Lori Kunkel, M.DIndependent · Compensation45,0000206,02100251,021
Jacob M. Chacko, M.DEmployee director00000
09

Board fee structure and ownership guideline

Annual cash retainer$40,000
Annual equity retainer
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)20,000 / 20,000
Stock ownership guideline
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$310,000
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$310,000

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Oric Pharmaceuticals2025Jacob Chacko$657,500$826,000$3,634,560$434,000$5,567,164

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Jacob ChackoDEF 14A2026-04-280001193125-26-186911Section “Summary Compensation Table” · page 42. As printed: 5,567,164. Filing ↗machine: r2 · c26 · span 435191–435200
2Section 01, Pratik MultaniDEF 14A2026-04-280001193125-26-186911Section “Summary Compensation Table” · page 42. As printed: 2,282,441. Filing ↗machine: r6 · c26 · span 444560–444569
3Section 01, Dominic PiscitelliDEF 14A2026-04-280001193125-26-186911Section “Summary Compensation Table” · page 42. As printed: 2,237,425. Filing ↗machine: r4 · c26 · span 439892–439901
4Section 03, Jacob Chacko PSUDEF 14A2026-04-280001193125-26-186911Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t126 · r2 · c15 · span 397337–397344
5Section 03, Jacob Chacko OPTIONDEF 14A2026-04-280001193125-26-186911Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t132 · r2 · c15 · span 434198–434207
6Section 03, Dominic Piscitelli OPTIONDEF 14A2026-04-280001193125-26-186911Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t132 · r4 · c15 · span 438899–438908
7Section 03, Pratik Multani OPTIONDEF 14A2026-04-280001193125-26-186911Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t132 · r6 · c15 · span 443567–443576
8Section 03, Dominic Piscitelli PSUDEF 14A2026-04-280001193125-26-186911Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t126 · r4 · c15 · span 399246–399253
9Section 03, Pratik Multani PSUDEF 14A2026-04-280001193125-26-186911Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t126 · r6 · c15 · span 401137–401144
10Section 07, pay ratio10-K2026-02-230001193125-26-064005Section “CEO Pay Ratio”. As printed: —. Filing ↗
11Section 08, Richard Heyman, Ph.DDEF 14A2026-04-280001193125-26-186911Section “Director Compensation”. As printed: 306,021. Filing ↗machine: t81 · r2 · c11 · span 251091–251098
12Section 08, Mardi C. DierDEF 14A2026-04-280001193125-26-186911Section “Director Compensation”. As printed: 266,021. Filing ↗machine: t81 · r3 · c11 · span 252217–252224
13Section 08, Angie You, Ph.DDEF 14A2026-04-280001193125-26-186911Section “Director Compensation”. As printed: 258,521. Filing ↗machine: t81 · r6 · c11 · span 255656–255663
14Section 08, Steven L. HoerterDEF 14A2026-04-280001193125-26-186911Section “Director Compensation”. As printed: 258,521. Filing ↗machine: t81 · r4 · c11 · span 253372–253379
15Section 08, Lori Kunkel, M.DDEF 14A2026-04-280001193125-26-186911Section “Director Compensation”. As printed: 251,021. Filing ↗machine: t81 · r5 · c11 · span 254502–254509
16Section 08, Jacob M. Chacko, M.DDEF 14A2026-04-280001193125-26-186911Section “Director Compensation”. As printed: 0. Filing ↗
17Section 02, Richard A. Heyman 2026-07-06Form 42026-07-080001584759-26-000012Insider equity transaction reported since the proxy statement. Filing ↗
18Section 02, Richard A. Heyman 2026-07-24Form 42026-07-280001584759-26-000015Insider equity transaction reported since the proxy statement. Filing ↗
19Section 02, Richard A. Heyman 2026-07-24Form 42026-07-280001584759-26-000015Insider equity transaction reported since the proxy statement. Filing ↗
20Section 02, Richard A. Heyman 2026-07-24Form 42026-07-280001584759-26-000015Insider equity transaction reported since the proxy statement. Filing ↗
21Section 02, Richard A. Heyman 2026-07-24Form 42026-07-280001584759-26-000015Insider equity transaction reported since the proxy statement. Filing ↗
22Section 06, 2026 voteForm 8-K2026-06-220001193125-26-277511Item 5.07 · say-on-pay result. As reported: 98.6% (votes for as printed: 88,453,809). Filing ↗
23Section 03b vehicle mix (computed)ComputedcomputedRSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
24Section 09b board cost (computed)ComputedcomputedCash 310,000 + equity 0 + all other 0 = 310,000, summed across the director compensation table rows.machine: formula: Σ = 310,000
25Oric Pharmaceuticals (subject), Section 10b CEO totalDEF 14A2026-04-280001193125-26-186911CEO total compensation as printed in Oric Pharmaceuticals's own proxy. As printed: 5,567,164. Filing ↗machine: r2 · c26 · span 435191–435200